Hwg Holdings LP Acadia Pharmaceuticals Inc Call Options Transaction History

Hwg Holdings LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2019 Apr 29, 2019	SELL	$16.17 - $27.38 $491,568 - $832,352	-30,400 Closed	0 $0
Q4 2018 Feb 19, 2019	SELL	$14.32 - $22.92 $15,752 - $25,212	-1,100 Reduced 3.49%	30,400 $492,000
Q1 2018 Apr 27, 2018	SELL	$22.47 - $32.33 $33,705 - $48,495	-1,500 Reduced 4.55%	31,500 $708,000
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $973,170 - $1.27 Million	33,000	33,000 $1.24 Million

316

164M

855K

350K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.93B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Hwg Holdings LP, based on Form 13F filings with the SEC.

Stay updated on Hwg Holdings LP with notifications on news.